Used in pharmaceutical research as a key intermediate in the synthesis of dopamine receptor ligands. Shows potential in the development of treatments for neurological disorders such as Parkinson’s disease and schizophrenia due to its ability to selectively bind to dopamine D1 and D2 receptors. Also employed in studies exploring cognitive enhancement and neuroprotection. Its structure supports high blood-brain barrier permeability, making it valuable in central nervous system drug design.